The cellular basis of cortisone-induced immunosuppression of the antibody response studied by its reversal in vitro.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells; D000961:Antilymphocyte Serum; D001202:Ascitic Fluid / Q000276:immunology; D002448:Cell Adhesion; D002478:Cells, Cultured; D003348:Cortisone / Q000494:pharmacology*; D004912:Erythrocytes / Q000276:immunology; D005408:Flagellin; D006462:Hemolytic Plaque Technique; D007165:Immunosuppression Therapy; D008212:Lymphocyte Depletion; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008297:Male; D008623:Mercaptoethanol / Q000494:pharmacology; D051379:Mice; D008806:Mice, Inbred AKR; D008808:Mice, Inbred CBA; D010567:Pertussis Vaccine; D012475:Salmonella / Q000276:immunology; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000166:cytology; D013601:T-Lymphocytes / Q000276:immunology
D000961:Antilymphocyte Serum; D010567:Pertussis Vaccine; D005408:Flagellin; D008623:Mercaptoethanol; D003348:Cortisone